Inari Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Inari Medical generated cash of $35,927,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,171,000 last year. Net change in cash is therefore -$21,014,000.
Cash Flow
| 2018 | -10.89M | -753K | 26.75M |
|---|---|---|---|
| 2019 | -4.93M | -3.14M | 10.22M |
| 2020 | 1.91M | -55.43M | 144.11M |
| 2021 | 25.48M | -51.02M | 4.07M |
| 2022 | -13.97M | -195.21M | 177.13M |
| 2023 | 35.92M | -58.01M | 1.17M |
NARI Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 60.22M | 92.75M | 114.61M | 24.02M | 21.88M | 6.77M |
Operating activities | ||||||
Net income | -1.63M | -29.26M | 9.84M | 13.78M | -1.19M | -10.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 10.73M | 7.11M | 4.30M | 1.38M | 613.52K | 283K |
Stock-based compensation expense | 40.33M | 28.67M | 25.44M | 3.52M | 504.8K | 0 |
| Deferred income tax benefit | 40.33M | 28.67M | 25.44M | 3.52M | 504.8K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -11.05M | -17.03M | -14.36M | -16.70M | -8.95M | -2.16M |
Inventories | -7.43M | -11.68M | -10.48M | -6.64M | -2.87M | -558K |
Accounts payable | 344K | 1.14M | 3.51M | 498K | 1.83M | 372K |
Cash generated by operating activities | 35.92M | -13.97M | 25.48M | 1.91M | -4.93M | -10.89M |
Investing activities | ||||||
Purchases Of Investments | -406.73M | -497.86M | -134.37M | -49.97M | 0 | 0 |
Investments In Property Plant And Equipment | -4.71M | -9.95M | -13.64M | -5.46M | -3.14M | -753K |
Acquisitions Net | -240.41M | 185.26M | 37.37M | 0 | 0 | 0 |
Cash generated by investing activities | -58.01M | -195.21M | -51.02M | -55.43M | -3.14M | -753K |
Financing activities | ||||||
Common Stock Issued | 9.92M | 182.81M | 6.42M | 164.36M | 127.20K | 26.93M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -2.35M | -25K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -30.25M | 9.86M | 0 |
Cash used in financing activities | 1.17M | 177.13M | 4.07M | 144.11M | 10.22M | 26.75M |
Net Change In Cash | -21.01M | -32.53M | -21.86M | 90.59M | 2.14M | 15.11M |
Cash at end of period | 39.20M | 60.22M | 92.75M | 114.61M | 24.02M | 21.88M |
| Data source | Data source | Data source | Data source |